(Q36914411)

English

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

scientific article published on 14 December 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

cholangiocarcinoma

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Edgar Ben-Josef

4

object named as

Edgar Ben-Josef

0 references

7

object named as

Eunice L Kwak

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jeffrey W Clark

9

object named as

Jeffrey W Clark

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

21

object named as

David P Ryan

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lawrence S Blaszkowsky

6

object named as

Lawrence S Blaszkowsky

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Theodore S Hong

1

object named as

Theodore S Hong

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Jennifer Y Wo

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Beow Y Yeap

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Erin I McDonnell

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jill N Allen

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lipika Goyal

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Janet E Murphy

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Milind M Javle

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

John A Wolfgang

13

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lorraine C Drapek

14

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ronald S Arellano

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Harvey J Mamon

16

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

John T Mullen

17

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sam S Yoon

18

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Kenneth K Tanabe

19

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Cristina R Ferrone

20

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Thomas F DeLaney

22

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Christopher H Crane

23

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Andrew X Zhu

24

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

14 December 2015

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

34

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

460-468

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Limitations of conventional doses of chemoradiation for unresectable biliary cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Partial irradiation of the liver.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

29 September 2017

Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

4 September 2018

Stereotactic body radiotherapy for primary hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

4 September 2018

The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

4 September 2018

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

4 September 2018

A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

4 September 2018

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

4 September 2018

Proton beam therapy for unresectable intrahepatic cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4872014

20 October 2018

Proton Radiotherapy for Liver Tumors: Dosimetric Advantages Over Photon Plans

1 reference

https://pubmed.ncbi.nlm.nih.gov/26668346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26668346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26668346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication

1 reference

https://pubmed.ncbi.nlm.nih.gov/26668346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic body radiotherapy for unresectable cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26668346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2015.64.2710

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36914411&oldid=2081562016"